FDA Inspection 1321692 — RBC Development, LLC. dba RBC Medical Innovations dba Vantage Medtech

RBC Development, LLC. dba RBC Medical Innovations dba Vantage Medtech — FEI 3043527620

The FDA completed an inspection of RBC Development, LLC. dba RBC Medical Innovations dba Vantage Medtech on June 5, 2026 in Olathe, KS. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 5, 2026
Fiscal Year
2026
Product Type
Devices
Project Area
Project Evaluation: Devices
Location
Olathe, KS (United States)